Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review.
Bossart S, Daneluzzi C, Cazzaniga S, Ramelet AA, Uthoff H, Seyed Jafari SM, Baumgartner M, Hunger RE, Heidemeyer K, Willenberg T.
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):274-283. doi: 10.1111/jdv.18639. Epub 2022 Oct 17.
Foam sclerotherapy.
Alder G, Lees T.
Phlebology. 2015 Nov;30(2 Suppl):18-23. doi: 10.1177/0268355515589536.
Consensus for sclerotherapy.
Weiss MA, Hsu JT, Neuhaus I, Sadick NS, Duffy DM.
Dermatol Surg. 2014 Dec;40(12):1309-18. doi: 10.1097/DSS.0000000000000225.
Sclerotherapy basics.
Parsons ME.
Dermatol Clin. 2004 Oct;22(4):501-8, xi. doi: 10.1016/j.det.2004.03.017.
Catheter-directed sclerotherapy.
Parsi K.
Phlebology. 2009 Jun;24(3):98-107. doi: 10.1258/phleb.2009.009010.
Endoscopic sclerotherapy.
Terblanche J, Krige JE, Bornman PC.
Surg Clin North Am. 1990 Apr;70(2):341-59. doi: 10.1016/s0039-6109(16)45085-1.
Understanding sclerotherapy.
Marting B.
Plast Surg Nurs. 2000 Winter;20(4):209-15, 229. doi: 10.1097/00006527-200020040-00003.
Small-vessel sclerotherapy.
Sadick N, Li C.
Dermatol Clin. 2001 Jul;19(3):475-81, viii. doi: 10.1016/s0733-8635(05)70288-6.
The treatment of esophageal varices.
Terblanche J, Krige JE, Bornman PC.
Annu Rev Med. 1992;43:69-82. doi: 10.1146/annurev.me.43.020192.000441.
Postsclerotherapy compression: A systematic review.
Tan MKH, Salim S, Onida S, Davies AH.
J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):264-274. doi: 10.1016/j.jvsv.2020.07.011. Epub 2020 Aug 10.
